Pluristem's PLX cells safe in animal model

Pluristem Therapeutics (PSTI) rallies 3.6% premarket.

The company says its PLX cells "proved to be safe in an animal study assessing maternal and fetal toxicity."

When administered intramuscularly in pregnant rats, the PLX-PAD cells "did not result in any maternal or fetal toxicity."

Here's CEO Zami Aberman: "This study, together with the work performed by Dr. Brett Mitchell from Texas A&M College of Medicine,suggesting that our PLX-PAD cells are efficacious in preeclamptic animal models, is an important milestone towards our goal of initiating clinical trials for preeclampsia." (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs